Molecular testing, biochemical analysis, and the well-established genotype-phenotype correlations for MEN2 patients provide information about signaling processes by which RET mutations cause tumors, yet, exact mechanisms of specific oncogenic pathways are not fully understood especially for advanced stage MTC and metastasis. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.